| 4.3 |
12.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 3.6 |
10.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 3.5 |
10.4 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 3.5 |
13.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 3.4 |
24.1 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 3.3 |
9.8 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 3.1 |
12.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 3.1 |
9.2 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 3.0 |
15.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 3.0 |
11.9 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 2.9 |
2.9 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 2.8 |
8.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 2.5 |
7.6 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 2.5 |
7.6 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 2.5 |
2.5 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 2.5 |
5.0 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 2.5 |
9.8 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.5 |
12.3 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 2.4 |
16.6 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 2.3 |
7.0 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 2.3 |
7.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.2 |
8.9 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 2.2 |
2.2 |
GO:0071103 |
DNA conformation change(GO:0071103) |
| 2.1 |
6.3 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 2.1 |
6.2 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 2.1 |
4.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 2.0 |
8.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.0 |
17.8 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 2.0 |
2.0 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 2.0 |
5.9 |
GO:0030421 |
defecation(GO:0030421) |
| 2.0 |
3.9 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
| 2.0 |
7.8 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 1.9 |
5.7 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 1.9 |
13.2 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.9 |
1.9 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.8 |
9.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.8 |
12.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 1.8 |
5.5 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.8 |
14.6 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 1.8 |
5.5 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.8 |
7.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.8 |
1.8 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 1.8 |
5.4 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.8 |
1.8 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.8 |
8.9 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.7 |
5.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 1.7 |
5.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 1.7 |
11.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 1.7 |
5.0 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.6 |
6.6 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.6 |
4.9 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 1.6 |
4.9 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 1.6 |
4.8 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.6 |
8.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 1.6 |
12.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.6 |
4.7 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 1.6 |
17.3 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 1.6 |
7.8 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.5 |
13.8 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.5 |
6.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.5 |
4.6 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 1.5 |
10.6 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 1.5 |
4.5 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 1.5 |
3.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.5 |
9.0 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.5 |
7.5 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 1.5 |
4.5 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.5 |
3.0 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 1.5 |
4.4 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 1.5 |
22.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 1.5 |
4.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.5 |
5.8 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.4 |
7.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.4 |
8.4 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.4 |
4.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.4 |
4.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.4 |
1.4 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 1.3 |
2.7 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 1.3 |
4.0 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 1.3 |
5.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 1.3 |
4.0 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.3 |
4.0 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 1.3 |
14.6 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 1.3 |
5.3 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 1.3 |
11.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 1.3 |
2.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.3 |
10.4 |
GO:0072615 |
interleukin-17 secretion(GO:0072615) |
| 1.3 |
7.7 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 1.3 |
5.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.3 |
1.3 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 1.3 |
1.3 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 1.3 |
5.1 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 1.3 |
5.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.3 |
6.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.3 |
1.3 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 1.3 |
2.5 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 |
1.3 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.3 |
26.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.2 |
5.0 |
GO:0038027 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.2 |
12.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.2 |
3.7 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 1.2 |
3.7 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.2 |
6.1 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 1.2 |
8.5 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 1.2 |
6.0 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.2 |
1.2 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.2 |
1.2 |
GO:0015744 |
succinate transport(GO:0015744) |
| 1.2 |
3.5 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 1.2 |
3.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 1.2 |
1.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 1.2 |
1.2 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 1.2 |
1.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 1.2 |
1.2 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 1.2 |
3.5 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.2 |
1.2 |
GO:1902993 |
positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 1.1 |
3.4 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 1.1 |
5.6 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.1 |
4.5 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.1 |
10.1 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 1.1 |
8.9 |
GO:0007440 |
foregut morphogenesis(GO:0007440) |
| 1.1 |
4.4 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.1 |
4.4 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.1 |
5.5 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 1.1 |
14.2 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 1.1 |
3.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 1.1 |
2.2 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.1 |
14.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.1 |
2.2 |
GO:1904347 |
intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
| 1.1 |
10.8 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 1.1 |
6.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.1 |
10.6 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 1.0 |
4.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 1.0 |
4.2 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.0 |
3.1 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 1.0 |
1.0 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 1.0 |
1.0 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 1.0 |
4.1 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.0 |
3.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 1.0 |
14.3 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 1.0 |
10.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 1.0 |
3.1 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 1.0 |
5.1 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 1.0 |
7.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.0 |
3.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.0 |
3.0 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.0 |
8.0 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.0 |
3.0 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.0 |
7.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.0 |
2.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.0 |
1.0 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.0 |
3.9 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.0 |
21.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 1.0 |
2.9 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 1.0 |
7.8 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 1.0 |
2.9 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.0 |
2.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 1.0 |
3.8 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.0 |
1.0 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.9 |
4.7 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.9 |
4.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.9 |
0.9 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.9 |
1.9 |
GO:0051316 |
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.9 |
8.4 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.9 |
3.7 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 |
5.6 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.9 |
11.1 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.9 |
1.8 |
GO:0021649 |
vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.9 |
0.9 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.9 |
3.7 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.9 |
3.6 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.9 |
5.4 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.9 |
6.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.9 |
2.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.9 |
1.8 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.9 |
2.7 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.9 |
7.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.9 |
9.8 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.9 |
4.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.9 |
5.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.9 |
0.9 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.9 |
2.6 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.9 |
1.7 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.9 |
5.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.9 |
2.6 |
GO:0072103 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.9 |
3.5 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.9 |
3.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.9 |
9.5 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.9 |
6.0 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.9 |
3.4 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.9 |
4.3 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.9 |
20.4 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.8 |
7.6 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.8 |
3.4 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 |
3.4 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.8 |
2.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.8 |
0.8 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.8 |
0.8 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.8 |
1.6 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.8 |
4.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.8 |
2.5 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.8 |
2.5 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 0.8 |
4.1 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.8 |
2.4 |
GO:0006601 |
creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
| 0.8 |
3.3 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.8 |
3.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.8 |
10.5 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.8 |
1.6 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.8 |
0.8 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.8 |
3.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.8 |
2.4 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 0.8 |
0.8 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.8 |
1.6 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.8 |
15.1 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.8 |
2.4 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.8 |
4.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.8 |
1.6 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.8 |
3.9 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.8 |
2.3 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.8 |
3.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.8 |
3.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.8 |
1.5 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.8 |
3.0 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.8 |
0.8 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.8 |
7.5 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.8 |
2.3 |
GO:0019062 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.8 |
2.3 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 |
3.8 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.7 |
1.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.7 |
5.2 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.7 |
4.5 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.7 |
1.5 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.7 |
3.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 |
6.7 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.7 |
0.7 |
GO:2000738 |
positive regulation of stem cell differentiation(GO:2000738) |
| 0.7 |
3.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.7 |
5.9 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.7 |
1.5 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.7 |
3.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.7 |
2.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.7 |
7.4 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.7 |
3.6 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 |
1.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 |
6.5 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.7 |
0.7 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.7 |
7.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.7 |
2.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.7 |
1.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.7 |
10.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.7 |
4.3 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.7 |
6.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.7 |
0.7 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.7 |
1.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.7 |
1.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 |
2.1 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.7 |
10.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.7 |
2.8 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.7 |
9.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.7 |
2.1 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
3.5 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.7 |
3.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.7 |
4.8 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.7 |
0.7 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.7 |
8.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.7 |
2.1 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 |
4.8 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.7 |
2.0 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.7 |
2.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.7 |
3.4 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.7 |
0.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.7 |
3.4 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.7 |
3.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.7 |
0.7 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.7 |
1.3 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 0.7 |
2.0 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.7 |
2.7 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.7 |
4.0 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.7 |
0.7 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.7 |
3.9 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.7 |
0.7 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.7 |
1.3 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.6 |
4.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.6 |
1.3 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.6 |
1.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.6 |
0.6 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.6 |
4.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.6 |
1.9 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.6 |
5.7 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.6 |
0.6 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.6 |
0.6 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 |
1.3 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 |
2.5 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.6 |
1.2 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.6 |
4.4 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.6 |
1.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.6 |
0.6 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.6 |
0.6 |
GO:1903010 |
regulation of bone development(GO:1903010) |
| 0.6 |
2.5 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.6 |
1.8 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.6 |
3.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.6 |
3.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.6 |
0.6 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.6 |
0.6 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.6 |
4.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.6 |
3.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.6 |
1.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.6 |
4.2 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.6 |
4.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.6 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.6 |
5.9 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.6 |
0.6 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.6 |
3.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.6 |
4.1 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.6 |
15.3 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.6 |
1.8 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.6 |
3.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.6 |
3.5 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.6 |
1.7 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.6 |
2.9 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.6 |
0.6 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.6 |
0.6 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.6 |
2.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.6 |
1.7 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.6 |
0.6 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.6 |
1.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.6 |
1.1 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.6 |
1.1 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.6 |
14.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.6 |
3.9 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.6 |
0.6 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.6 |
1.7 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.6 |
2.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 |
6.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.6 |
2.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
2.2 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 |
1.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.6 |
3.3 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.6 |
0.6 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.6 |
1.7 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.6 |
2.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.6 |
13.9 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.6 |
14.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.6 |
1.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 |
4.4 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.6 |
0.6 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.6 |
6.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.6 |
2.2 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.5 |
2.7 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.5 |
4.9 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.5 |
5.5 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.5 |
3.3 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.5 |
2.7 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.5 |
2.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.5 |
1.6 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.5 |
0.5 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.5 |
1.6 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.5 |
1.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
0.5 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.5 |
1.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.5 |
2.7 |
GO:0035089 |
establishment of apical/basal cell polarity(GO:0035089) |
| 0.5 |
3.2 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.5 |
3.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.5 |
1.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 |
1.6 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.5 |
1.6 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.5 |
0.5 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.5 |
1.6 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.5 |
1.6 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.5 |
1.5 |
GO:0072081 |
proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.5 |
0.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.5 |
6.6 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.5 |
4.6 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 |
3.6 |
GO:0051195 |
negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.5 |
4.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
5.1 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.5 |
7.1 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.5 |
1.5 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 |
5.1 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.5 |
2.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.5 |
1.5 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.5 |
12.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.5 |
0.5 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.5 |
3.0 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.5 |
0.5 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.5 |
1.5 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.5 |
6.0 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 |
1.0 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 |
2.5 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.5 |
0.5 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.5 |
2.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.5 |
3.0 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.5 |
4.0 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.5 |
5.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.5 |
1.0 |
GO:0009814 |
defense response, incompatible interaction(GO:0009814) |
| 0.5 |
7.4 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.5 |
10.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.5 |
1.0 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.5 |
16.7 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.5 |
2.0 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.5 |
1.0 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.5 |
2.9 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.5 |
2.4 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.5 |
1.5 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.5 |
3.9 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.5 |
1.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.5 |
3.4 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 |
1.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.5 |
3.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 |
1.0 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.5 |
1.9 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.5 |
1.0 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.5 |
1.9 |
GO:1900150 |
regulation of defense response to fungus(GO:1900150) |
| 0.5 |
4.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.5 |
0.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.5 |
1.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.5 |
9.0 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.5 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 |
2.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.5 |
0.9 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.5 |
14.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 |
1.4 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.5 |
1.9 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.5 |
1.9 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.5 |
1.4 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.5 |
0.5 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.5 |
2.8 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.5 |
1.4 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.5 |
0.9 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.5 |
2.3 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.5 |
6.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.5 |
0.5 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) spindle assembly involved in meiosis(GO:0090306) |
| 0.5 |
0.9 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.5 |
1.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.5 |
0.9 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.5 |
2.3 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.4 |
1.8 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
11.6 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.4 |
0.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 |
2.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.4 |
7.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.4 |
1.3 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.4 |
4.0 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.4 |
1.3 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.4 |
3.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.4 |
0.9 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.4 |
0.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.4 |
1.3 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 |
3.1 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.4 |
0.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.4 |
1.3 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 |
1.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 |
1.3 |
GO:0042748 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.4 |
0.4 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.4 |
1.3 |
GO:0086028 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.4 |
8.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
2.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 |
0.9 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.4 |
1.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 |
3.4 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.4 |
4.7 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.4 |
6.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 |
1.3 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.4 |
0.8 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
3.4 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.4 |
5.1 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.4 |
9.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 |
12.6 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.4 |
4.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
1.3 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 |
2.1 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.4 |
1.7 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.4 |
1.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.4 |
2.9 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
0.8 |
GO:2000319 |
negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.4 |
2.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.4 |
2.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.4 |
0.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 |
2.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.4 |
4.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 |
0.8 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.4 |
5.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
2.4 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.4 |
2.8 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 |
1.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.4 |
0.8 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
1.6 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.4 |
1.2 |
GO:0002481 |
antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.4 |
0.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.4 |
0.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.4 |
3.6 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 |
0.4 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.4 |
2.0 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.4 |
1.6 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.4 |
0.4 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.4 |
6.7 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.4 |
0.8 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
2.4 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.4 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.4 |
1.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.4 |
1.6 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.4 |
2.7 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.4 |
0.8 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.4 |
2.7 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.4 |
1.2 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.4 |
1.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 |
1.9 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.4 |
0.8 |
GO:2000780 |
negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.4 |
7.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.4 |
1.5 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.4 |
1.5 |
GO:1903028 |
regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.4 |
9.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.4 |
4.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 |
5.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.4 |
0.7 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.4 |
2.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.4 |
1.1 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 |
0.7 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.4 |
5.2 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 |
1.1 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.4 |
0.4 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.4 |
0.4 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.4 |
0.4 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.4 |
0.7 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.4 |
2.2 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.4 |
0.7 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.4 |
1.8 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.4 |
1.8 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.4 |
0.7 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.4 |
0.7 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.4 |
0.7 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.4 |
0.4 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.4 |
1.1 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.4 |
2.5 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.4 |
1.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 |
3.6 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 |
2.1 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.4 |
4.3 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.4 |
0.7 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 |
1.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 |
2.9 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
0.7 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.4 |
3.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
2.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.4 |
1.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 |
5.0 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.4 |
3.5 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.4 |
0.4 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.4 |
0.7 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 0.4 |
1.8 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.3 |
2.1 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
1.0 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.3 |
0.7 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.3 |
0.7 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 |
2.8 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
0.7 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.3 |
0.7 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.3 |
1.7 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
0.3 |
GO:1901033 |
positive regulation of response to reactive oxygen species(GO:1901033) |
| 0.3 |
2.4 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 |
1.4 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.3 |
0.7 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.3 |
1.0 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
2.0 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.3 |
1.0 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
0.3 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.3 |
0.3 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.3 |
11.2 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.3 |
0.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
1.0 |
GO:0003339 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.3 |
9.1 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.3 |
1.3 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
1.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 |
5.3 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.3 |
2.7 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.3 |
3.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
1.0 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.3 |
1.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.3 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.3 |
13.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.3 |
5.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.3 |
1.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.3 |
6.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.3 |
0.3 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) |
| 0.3 |
1.9 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
1.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
1.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.3 |
2.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.3 |
2.5 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
1.3 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 |
2.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
3.8 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.3 |
0.6 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.3 |
0.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.3 |
1.2 |
GO:1903527 |
regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.3 |
0.6 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.3 |
7.8 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.3 |
2.5 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.3 |
0.9 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.3 |
0.3 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 |
0.6 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.3 |
0.6 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.3 |
3.4 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.3 |
2.7 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
1.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.3 |
4.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
1.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.3 |
0.6 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.3 |
1.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.3 |
0.6 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.3 |
3.9 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.3 |
0.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
0.3 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.3 |
0.6 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.3 |
3.3 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.3 |
4.8 |
GO:0044319 |
wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
| 0.3 |
3.0 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.3 |
0.9 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
1.5 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 |
1.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.3 |
0.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 |
2.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.3 |
12.9 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.3 |
0.6 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.3 |
1.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.3 |
0.6 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.3 |
1.5 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 |
0.9 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.3 |
0.9 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.3 |
2.3 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.3 |
2.0 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
1.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.3 |
1.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
1.7 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.3 |
1.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.3 |
1.1 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.3 |
2.0 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.3 |
3.4 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.3 |
0.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
1.1 |
GO:0015786 |
UDP-glucose transport(GO:0015786) protein O-linked fucosylation(GO:0036066) |
| 0.3 |
0.3 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 |
1.4 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.3 |
1.4 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 |
0.8 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
0.3 |
GO:0001798 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type I hypersensitivity(GO:0001812) type II hypersensitivity(GO:0002445) positive regulation of hypersensitivity(GO:0002885) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 |
0.6 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.3 |
1.9 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.3 |
4.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.3 |
0.5 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.3 |
2.7 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.3 |
1.1 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.3 |
1.4 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 |
1.4 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.3 |
1.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.3 |
4.6 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.3 |
1.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.3 |
1.1 |
GO:0034249 |
negative regulation of cellular amide metabolic process(GO:0034249) |
| 0.3 |
0.8 |
GO:0034473 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.3 |
1.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 |
0.3 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.3 |
2.4 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.3 |
13.0 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.3 |
2.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.3 |
3.7 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.3 |
3.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
0.3 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.3 |
1.6 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.3 |
1.8 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.3 |
1.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 |
0.3 |
GO:0033088 |
negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 |
0.8 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.3 |
0.5 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.3 |
1.3 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.3 |
0.5 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 |
4.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
1.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
0.3 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.3 |
0.8 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 |
0.3 |
GO:0045410 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 |
1.5 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
0.3 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.3 |
0.5 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.3 |
2.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
3.3 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.3 |
0.3 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
1.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
10.5 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
0.5 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.3 |
1.0 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
0.5 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.2 |
0.7 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.2 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.2 |
1.5 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
6.0 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
1.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
3.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.2 |
2.2 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.2 |
1.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
1.2 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.2 |
2.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
0.7 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
0.7 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 |
0.2 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.2 |
0.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
1.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
12.4 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.2 |
1.7 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
2.4 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.2 |
1.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.5 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
1.2 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 |
1.2 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 |
0.7 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 |
1.2 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 |
0.2 |
GO:1902373 |
negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 |
5.6 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.2 |
2.8 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 |
5.1 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.2 |
0.9 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.2 |
3.0 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.2 |
2.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
0.9 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.2 |
1.4 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.2 |
0.5 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
8.8 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.2 |
1.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
0.7 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
0.2 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
0.7 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.1 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 |
0.7 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
0.7 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.2 |
1.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
1.6 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.2 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
0.9 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
0.9 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
0.7 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.2 |
2.4 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
2.8 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
1.1 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.2 |
5.0 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
8.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.2 |
1.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
0.4 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.2 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
1.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
3.2 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.2 |
0.2 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
1.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
3.4 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.2 |
0.6 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.6 |
GO:1902592 |
viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 |
1.1 |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.2 |
0.6 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
1.7 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.2 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.4 |
GO:0099550 |
trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.2 |
0.4 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.2 |
0.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
1.0 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 |
1.7 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
4.2 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.2 |
0.2 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.2 |
0.6 |
GO:0009221 |
pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.2 |
0.2 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
2.9 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
0.8 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
1.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.2 |
0.6 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
2.2 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
1.2 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.2 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
0.4 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.2 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.2 |
2.6 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.2 |
0.8 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.2 |
0.4 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.2 |
1.4 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
1.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.2 |
0.6 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 |
0.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
1.6 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.2 |
1.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
1.4 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 |
0.2 |
GO:1904809 |
dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.2 |
1.2 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.8 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.6 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
1.3 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.2 |
0.4 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.2 |
1.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
1.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
0.4 |
GO:1904645 |
response to beta-amyloid(GO:1904645) |
| 0.2 |
0.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.4 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
1.7 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.2 |
0.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 |
1.1 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
0.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
0.6 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
0.7 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
2.8 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 |
8.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.2 |
0.4 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.9 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.2 |
1.1 |
GO:0032366 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.2 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 |
0.2 |
GO:0010935 |
macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
| 0.2 |
0.7 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.2 |
2.0 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.2 |
0.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.2 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.2 |
0.5 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
0.7 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.4 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.2 |
4.9 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 |
4.0 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
1.1 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
0.2 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.2 |
1.0 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 |
1.2 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
1.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.2 |
0.5 |
GO:0048209 |
regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.2 |
0.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.2 |
1.0 |
GO:0032196 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.2 |
0.7 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
1.5 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.2 |
0.3 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
0.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.5 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 |
0.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
2.0 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.2 |
1.3 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.2 |
1.2 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
0.7 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.2 |
0.2 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.2 |
4.4 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.2 |
1.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
2.1 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 |
1.6 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
0.3 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 |
1.4 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
0.8 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
0.5 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.2 |
0.2 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.2 |
0.3 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.2 |
0.5 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.4 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 |
1.5 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.7 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
1.6 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.1 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 |
0.7 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.9 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.4 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.6 |
GO:1901991 |
negative regulation of mitotic cell cycle phase transition(GO:1901991) |
| 0.1 |
0.4 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.9 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.1 |
0.4 |
GO:0090224 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 |
1.4 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.1 |
1.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.3 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.1 |
1.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.4 |
GO:0097066 |
complement activation, alternative pathway(GO:0006957) response to thyroid hormone(GO:0097066) |
| 0.1 |
0.4 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
1.1 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.1 |
0.6 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
1.0 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.7 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.7 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
1.3 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.3 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.8 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.6 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.7 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.4 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.1 |
2.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.3 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 |
0.8 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.8 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
2.8 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.8 |
GO:1901911 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 |
0.4 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.7 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
2.0 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
0.5 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.5 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.7 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.1 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
0.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.4 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.1 |
1.3 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
1.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.4 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.4 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 |
0.4 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 |
4.2 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
1.6 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.4 |
GO:0043043 |
peptide biosynthetic process(GO:0043043) |
| 0.1 |
0.9 |
GO:0051570 |
regulation of histone H3-K9 methylation(GO:0051570) |
| 0.1 |
0.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.1 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 |
0.7 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.5 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.1 |
0.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.9 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.9 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.1 |
0.5 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 |
0.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.6 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.1 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
1.4 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.2 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
0.4 |
GO:0060896 |
neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) |
| 0.1 |
0.5 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
3.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
0.2 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.1 |
GO:0032660 |
regulation of interleukin-17 production(GO:0032660) |
| 0.1 |
1.4 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.3 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.6 |
GO:0019243 |
methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.5 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
1.1 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
4.2 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.1 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.6 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.1 |
1.3 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
1.7 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.1 |
2.9 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.3 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.1 |
0.7 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
1.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.2 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
1.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.7 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.3 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
2.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.4 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.5 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.1 |
0.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.7 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.4 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.8 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 |
0.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
1.2 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.6 |
GO:0051882 |
mitochondrial depolarization(GO:0051882) |
| 0.1 |
0.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.9 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.1 |
0.4 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.3 |
GO:0048308 |
organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.2 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.2 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.1 |
1.0 |
GO:1904353 |
regulation of telomere capping(GO:1904353) |
| 0.1 |
2.8 |
GO:0007098 |
centrosome cycle(GO:0007098) |
| 0.1 |
0.5 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.1 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
0.3 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.1 |
0.6 |
GO:0044346 |
fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.8 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.8 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.1 |
0.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.1 |
GO:0006399 |
tRNA metabolic process(GO:0006399) |
| 0.1 |
2.0 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.6 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
0.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.3 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.1 |
0.3 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.1 |
0.9 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
2.5 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.1 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.7 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.2 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
0.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.4 |
GO:0032369 |
negative regulation of lipid transport(GO:0032369) |
| 0.1 |
0.3 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.3 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.4 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
0.5 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.3 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.1 |
0.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
0.4 |
GO:0014886 |
regulation of skeletal muscle adaptation(GO:0014733) transition between slow and fast fiber(GO:0014886) skeletal muscle adaptation(GO:0043501) |
| 0.1 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
1.3 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.1 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.2 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.1 |
0.2 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.1 |
GO:0072172 |
ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
| 0.1 |
0.1 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.1 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.4 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.6 |
GO:0009994 |
oocyte differentiation(GO:0009994) |
| 0.1 |
0.6 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.1 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.1 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
2.3 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.7 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.5 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.3 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.3 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.7 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.1 |
0.7 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.3 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 |
1.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.3 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
1.0 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.4 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
0.1 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.1 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.4 |
GO:0071548 |
response to dexamethasone(GO:0071548) |
| 0.1 |
2.1 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.2 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.7 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.1 |
0.7 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.1 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
0.7 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.2 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.4 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.2 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.2 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
0.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.2 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
0.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.5 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.4 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 |
0.1 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 |
1.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.1 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.0 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.3 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.0 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 |
0.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.3 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.1 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.0 |
0.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.0 |
0.6 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.0 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.0 |
0.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.1 |
GO:0046967 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) cytosol to ER transport(GO:0046967) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.3 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.0 |
0.6 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.3 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.1 |
GO:1902309 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
0.1 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.8 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.0 |
0.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.4 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.1 |
GO:2001169 |
regulation of ATP biosynthetic process(GO:2001169) |
| 0.0 |
0.1 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 |
1.1 |
GO:0071229 |
cellular response to acid chemical(GO:0071229) |
| 0.0 |
0.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.2 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:0032042 |
mitochondrial DNA metabolic process(GO:0032042) |
| 0.0 |
0.1 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 |
0.0 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.0 |
0.2 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.0 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.0 |
0.1 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 |
0.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
1.4 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.3 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.0 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.0 |
0.1 |
GO:1903288 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.6 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.0 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.1 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.0 |
0.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.0 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.0 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.0 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.0 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.0 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.3 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.0 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 |
0.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.0 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.2 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.1 |
GO:0070723 |
response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
| 0.0 |
0.1 |
GO:0009118 |
regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
| 0.0 |
0.0 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.0 |
0.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.0 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.0 |
0.0 |
GO:0061365 |
positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.0 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.0 |
0.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.0 |
0.0 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.0 |
GO:2000726 |
negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.0 |
0.9 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.0 |
0.1 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.2 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.0 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.0 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.1 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
